UGT1A6 variants and deferiprone-induced ADRs: a complication-specific analysis in Iranian thalassemia patients
{{output}}
Aims: Deferiprone, an iron chelator, causes variable adverse drug reactions (ADRs) in β-thalassemia patients, suggesting a role for pharmacogenetic factors. To address the lack of comprehensive pharmacogenetic data, this study i... ...
